Periprocedural platelet inhibition with cangrelor in P2Y12-inhibitor naïve patients with acute coronary syndromes — A matched-control pharmacodynamic comparison in real-world patients-Reference-Cited by-同舟云学术

Periprocedural platelet inhibition with cangrelor in P2Y12-inhibitor naïve patients with acute coronary syndromes — A matched-control pharmacodynamic comparison in real-world patients

Published:2016-11 Issue: Volume:223 Page:848-851
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Droppa Michal,Spahn Pascal,Takhgiriev Khalid,Müller Karin A.L.,Alboji Ahmed,Straub Andreas,Rath Dominik,Jeong Young-Hoon,Gawaz Meinrad,Geisler Tobias

Funder

DFG

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction;Ahn;JACC Cardiovasc. Interv.,2012

2. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease;Geisler;Heart Br. Card. Soc.,2008

3. 2014 ESC/EACTS Guidelines on myocardial revascularization

4. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

5. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study;Gurbel;Circulation,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Stewardship: Evaluation of Platelet Reactivity-Guided Cangrelor Dosing Using the VerifyNow® Assay;Journal of Cardiovascular Pharmacology;2024-02-08

2. Optimal Antithrombotic Strategies in Cardiogenic Shock;Journal of Clinical Medicine;2024-01-03

3. Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study;Clinical Cardiology;2022-06-22

4. ACKR3 regulates platelet activation and ischemia-reperfusion tissue injury;Nature Communications;2022-04-05

5. The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation;Platelets;2021-08-09